Skip to content

How You Can Help Bring out the Benefits of Brain Stimulation


What happens when medication or psychotherapy prove to be ineffective for those with mental illnesses such as depression? One impressive treatment being used  at CAMH is rTMS (or Repetitive  Transcranial Magnetic Stimulation), a non-invasive technique that uses magnetic impulses to stimulate centres of the brain associated with depression, providing benefits to clients without some of the side effects of other interventions.

Up until now, rTMS has only been available to those fortunate enough to participate in research studies. People like Fahad, Jane and Gail, who have shared their stories of recovery. With your help, this may be about to change.

CAMH has submitted an application to Health Quality Ontario’s Ontario Health Technology Advisory Committee (OHTAC) to have rTMS recognized for public funding. Through review of evidence-based analysis, the efficacy and safety of rTMS treatments for those with treatment-resistant depression is being considered. The process includes a public consultation, and comments in support of the intervention are required from members of the public. You can read more about the public consultation here.

rTMS is recognized as one of the most important advances in psychiatry in decades, in particular because of its effectiveness in addressing treatment-resistant depression without the side effects often experienced with Electroconvulsive Therapy or ECT. rTMS has the potential to significantly improve the lives of the 30-50% of Ontarians with depression who do not respond to medications and/or psychotherapy. But bringing these kinds of therapies to widespread use can be a challenging, multi-tiered process.

How you can help

While CAMH enthusiastically supports OHTAC’s recommendation that rTMS be publicly funded, part of their recommendations stipulate that  access to rTMS be should be offered to patients only when electroconvulsive therapy has failed or is contraindicated. Our clinicians don’t believe that people should have to try ECT first. They think that rTMS should be available to patients with treatment-resistant depression when ECT is contraindicated or when the patient refuses to provide consent to ECT delivery.

This is where we need your help. If you would like to support the availability of rTMS, or if someone you know has had any experience with rTMS, please submit a comment via email to before November 25, 2015 in support of the application for public funding of rTMS.

Please share this message, and help make rTMS treatments a possibility in Ontario for those with limited options for treatment.


Here’s a sample letter to OHTAC based on a submission by Dr. Jeff Daskalakis of CAMH

One Comment Post a comment
  1. Clearly if this treatment works for some then it should be available. When newer treatments for cancer patients are developed they become available pretty fast . Mentally ill patients should not be denied treatment that might ameliorate their suffering . This is discrimination. Patricia Forsdyke.

    November 18, 2015

Leave a Reply to Patricia Forsdyke Cancel reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: